Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
6.81 (- 0.31)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

Conatus Update

Sep 2, 2014
View Presentation

View all »   RSSRecent Releases

Apr 1, 2015
Conatus Announces Proposed Public Offering of Common Stock

Mar 26, 2015
Conatus Announces Successful Top-Line Results From NAFLD/NASH Clinical Trial of Emricasan

View all »Events & Presentations

Mar 23, 2015
54th Annual Meeting of the Society of Toxicology
PDF View Poster  158.6 KB   Add to Briefcase

Mar 11, 2015
Conatus Pharmaceuticals Fourth Quarter 2014 Financial Results
Webcast Listen to webcast